257 related articles for article (PubMed ID: 16078246)
1. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Koss LG
Diagn Cytopathol; 2005 Sep; 33(3):219. PubMed ID: 16078246
[No Abstract] [Full Text] [Related]
2. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
3. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
4. Atypical ductal hyperplasia from stereotactic core biopsy of the breast.
Montgomery S
AJR Am J Roentgenol; 1996 May; 166(5):1230. PubMed ID: 8615279
[No Abstract] [Full Text] [Related]
5. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
7. Atypical ductal hyperplasia: a way to minimize underestimation in vacuum-assisted breast biopsy?
Zografos GC; Zagouri F; Sergentanis TN; Nonni A; Koulocheri D; Bramis J
Breast; 2008 Feb; 17(1):6. PubMed ID: 18083567
[No Abstract] [Full Text] [Related]
8. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
9. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
[TBL] [Abstract][Full Text] [Related]
10. Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?
Arora S; Menes TS; Moung C; Nagi C; Bleiweiss I; Jaffer S
Ann Surg Oncol; 2008 Mar; 15(3):843-7. PubMed ID: 17987337
[TBL] [Abstract][Full Text] [Related]
11. Papillary lesions of the breast.
Ibarra JA
Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
[TBL] [Abstract][Full Text] [Related]
12. Needle cytology of the breast. A quantitative and qualitative study of the cells of benign and malignant ductal neoplasia.
Dziura BR; Bonfiglio TA
Acta Cytol; 1979; 23(4):332-40. PubMed ID: 231367
[TBL] [Abstract][Full Text] [Related]
13. Significance of papillary lesions at percutaneous breast biopsy.
Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
[TBL] [Abstract][Full Text] [Related]
14. Fiberoptic ductoscopy-guided intraductal biopsy improve the diagnosis of nipple discharge.
Ling H; Liu GY; Lu JS; Love S; Zhang JX; Xu XL; Xu WP; Shen KW; Shen ZZ; Shao ZM
Breast J; 2009; 15(2):168-75. PubMed ID: 19292803
[TBL] [Abstract][Full Text] [Related]
15. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
Park K; Han S; Kim HJ; Kim J; Shin E
Histopathology; 2006 May; 48(6):702-7. PubMed ID: 16681686
[TBL] [Abstract][Full Text] [Related]
16. [Breast neoplasms: histological classification].
Sakamoto G
Nihon Rinsho; 2007 Jun; 65 Suppl 6():54-9. PubMed ID: 17682139
[No Abstract] [Full Text] [Related]
17. Breast pathology practice: most common problems in a consultation service.
Putti TC; Pinder SE; Elston CW; Lee AH; Ellis IO
Histopathology; 2005 Nov; 47(5):445-57. PubMed ID: 16241992
[TBL] [Abstract][Full Text] [Related]
18. Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy?
Hoang JK; Hill P; Cawson JN
Breast; 2008 Jun; 17(3):282-8. PubMed ID: 18063369
[TBL] [Abstract][Full Text] [Related]
19. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
Wiechmann L; Kuerer HM
Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
[TBL] [Abstract][Full Text] [Related]
20. Validity of needle core biopsy in the histological characterisation of mammary lesions.
Cipolla C; Fricano S; Vieni S; Amato C; Napoli L; Graceffa G; Latteri S; Latteri MA
Breast; 2006 Feb; 15(1):76-80. PubMed ID: 16473738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
